PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
1,380.00
+15.00 (1.10%)
Nov 13, 2026, 1:30 PM CST

PharmaEssentia Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26,76422,69321,05119,66610,3043,454
Short-Term Investments
-0.43----
Cash & Short-Term Investments
26,76422,69321,05119,66610,3043,454
Cash Growth
24.02%7.80%7.04%90.86%198.34%7.51%
Accounts Receivable
6,0074,4722,6241,312798.87466.04
Other Receivables
320.05176.79210.67236.0841.2227.17
Receivables
6,3274,6492,8341,548840.09493.22
Inventory
1,7461,3281,2871,4591,102861.38
Prepaid Expenses
782.42306.35163.58151.9255.6449.02
Other Current Assets
309.9267.0580.9671.181,07469.41
Total Current Assets
35,92929,04425,41722,89613,3754,927
Property, Plant & Equipment
7,2704,9023,3612,7331,018764.93
Long-Term Investments
1,707461.44542.44163.9243.2439.22
Other Intangible Assets
1,469235.12272.72267.91236.88246.25
Long-Term Deferred Tax Assets
1,9851,6931,120958.46483.42-
Other Long-Term Assets
800.341,076347.95249.72176.38221.13
Total Assets
49,16037,41131,06227,26915,3336,198

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
229.8156.73126.47128.88230.96176.38
Accrued Expenses
-1,7361,106970.52667.45405.5
Short-Term Debt
---21993.8820
Current Portion of Long-Term Debt
-5.9811.912.3612.1412.05
Current Portion of Leases
201.98202.31180.56211.8577.7678.59
Current Income Taxes Payable
1,255266.54-0.99--
Current Unearned Revenue
12.23-0.23---
Other Current Liabilities
5,4862,3131,132806.49568.16719.44
Total Current Liabilities
7,1854,6812,5572,1522,5501,412
Long-Term Debt
40.3544.8350.8162.7174.9887.09
Long-Term Leases
863.09602.91722.16892.29410.05338.51
Pension & Post-Retirement Benefits
-10.3811.0610.214.183.95
Long-Term Deferred Tax Liabilities
120.0684.3781.32105.968.22-
Other Long-Term Liabilities
29.1312.76170.2197.91143.64106.3
Total Liabilities
8,2385,4363,5933,3213,1911,948

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,2243,7963,4183,4033,0252,769
Additional Paid-In Capital
26,05624,10623,54724,09213,4214,697
Retained Earnings
13,4747,2442,974-631.19-4,186-2,811
Treasury Stock
-2,718-2,763-2,805-2,805-87.5-344.74
Comprehensive Income & Other
-114.47-408.75335.89-110.37-31.54-60.15
Shareholders' Equity
40,92231,97527,46923,94812,1414,250
Total Liabilities & Equity
49,16037,41131,06227,26915,3336,198

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,105856.03965.431,2001,569536.24
Net Cash (Debt)
25,65921,83720,08618,4668,7352,917
Net Cash Growth
24.02%8.72%8.77%111.40%199.41%13.71%
Net Cash Per Share
62.1253.0448.8546.5224.979.11
Filing Date Shares Outstanding
412.9411.72409.78407.9371.21336.14
Total Common Shares Outstanding
412.9411.72409.78407.9371.21336.14
Working Capital
28,74424,36322,86020,74410,8253,515
Book Value Per Share
99.1177.6667.0358.7132.7112.64
Tangible Book Value
39,45331,74027,19623,68011,9044,004
Tangible Book Value Per Share
95.5577.0966.3758.0532.0711.91
Land
-58.2458.2458.2458.2458.24
Buildings
-69.8270.8670.6370.6170.52
Machinery
-1,175811.38723.26534.93486.58
Construction In Progress
-3,0722,0111,188234.5636.49
Leasehold Improvements
-754.58429.87426.29371.12341.61